myocardial infarction

Sirus Therapeutics announces positive signals from Phase I siRNA trial
Clinical Trials Arena
Tue, 12/10/24 - 11:11 am
Sirus Therapeutics
clinical terials
siRNA
SRSD107
myocardial infarction
ischemic stroke
Myocardial Infarction: Three drug trials to watch in 2024
Clinical Trials Arena
Thu, 02/29/24 - 11:07 am
clinical trials
myocardial infarction
CeleCor
Zalunfiban
BioCardia
CardiAMP
Thrombolytic Science
TS-01
Viatris splashes out $350m on pair of Idorsia therapies
Pharmaphorum
Wed, 02/28/24 - 10:45 am
Viatris
Idorsia
lupus
myocardial infarction
selatogrel
cenerimod
CSL’s ‘big’ post-heart attack drug fails in Phase III trial
Clinical Trials Arena
Mon, 02/12/24 - 10:20 am
CSL
clinical trials
CSL112
myocardial infarction
heart attacks
Bayer's near-approval Farxiga rival meets goal in 2nd phase 3
Fierce Biotech
Mon, 05/10/21 - 10:03 am
Bayer
finerenone
Farxiga
clinical trials
cardiovascular disease
myocardial infarction
Vorapaxar For Patients With Previous MI And Merck's Bottom Line
Seeking Alpha
Sat, 10/6/12 - 11:46 am
Vorapaxar
Merck
myocardial infarction
Medicines Co. says cardiology group guidelines recommend Angiomax over Heparin
Yahoo/Fly on the Wall
Tue, 08/28/12 - 12:26 pm
Medicines Company
Angiomax
Heparin
myocardial infarction
CellProthera achieves a revolutionary breakthrough in the treatment of myocardial infarction with the support of the Alsace Region and the Alsace BioValley biocluster
Pipeline Review
Sun, 01/31/10 - 11:27 am
CellProthera
biotech
myocardial infarction